We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Lekha Gupta Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics Merck KGaA is in advanced talks to acquire SpringWorks, whose portfolio could bolster Merck's oncology ...

Merck & Co. (MRK) releases positive phase three data for its injectable-form cancer drug Keytruda. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to break down the ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Merck & Co has added another clinical-stage drug to its oncology pipeline via a licensing agreement with Finland's Orion for ODM-208, a prostate cancer candidate currently in phase 2 testing.

Merck & Co., Inc. (MRK) is a healthcare company that boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda approved for several types of cancer. The Rahway ...

Lekha Gupta Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics Merck KGaA is in advanced talks to acquire SpringWorks, whose portfolio could bolster Merck's oncology ...

Merck boasts more than six blockbuster drugs in its portfolio, with blockbuster PD-L1 inhibitor Keytruda being the key top-line driver. Keytruda, approved for several types of cancer, alone ...